TikTok user Bridget shed over 100 pounds using a weight loss drug... but her shocking slimdown has resulted in her being on ...
The EU lacks cohesive governance to deploy economic statecraft tools, such as sanctions and export controls, undermining ...
Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...
A new article proposes offering citizens over 50 a combined medication that includes a cocktail of blood pressure-lowering ...
Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.
Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.
The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...
The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...
At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results